The Animal Biotechnology market report offers a thorough competitive analysis, mapping key players’ strategies, market share, and business models. It provides insights into competitor dynamics, helping companies align their strategies with the current market landscape and future trends.

Global Animal Biotechnology Market is segmented By Product Type (Diagnostics Tests, Vaccines, Drugs, Reproductive and Genetic, Feed Additives, Others), By Application (Diagnosis of Animal Diseases, Treatment of Animal Diseases, Preventive Care of Animals, Drug Development, Others), By Animal Type (Companion, Livestock), By End User (Veterinary Laboratories, Point-of-Care Testing/In-house Testing, Veterinary Hospitals & Clinics, Others), By Geography

The global animal biotechnology market is forecasted to increase to around 60 billion U.S. dollars by the early 2030s. The animal biotech industry is composed of many different sectors and focuses on both companion animals and food animals. In 2023, the animal health market was estimated at 27 billion U.S. dollars.

Explore the Animal Biotechnology Global Market Report 2025 Market trends! Covers key players, growth rate 10.2% CAGR, market size $48.68 Billion, and forecasts to 2033. Get insights now!

Global Animal Biotechnology market size 2025 was XX Million. Animal Biotechnology Industry compound annual growth rate (CAGR) will be XX% from 2025 till 2033.

Global Animal Biotechnology Market size & share value expected to touch USD 56,949.40 Million by 2032, to grow at a CAGR of 8.8% during the forecast period.

Snapshot img

Animal Biotechnology Market Size 2025-2029

The animal biotechnology market size is forecast to increase by USD 4.47 billion at a CAGR of 3.3% between 2024 and 2029.

The market is experiencing significant growth, driven by the increasing strategies of market players to expand their product portfolios and geographical reach. This trend is particularly evident in the development of innovative solutions for animal health and productivity. However, the market also faces challenges, including the increasing prevalence of animal diseases, which necessitate the need for more accurate and timely diagnostic tests. This presents an opportunity for companies to invest in research and development of advanced diagnostic tools and services. Despite this potential, the market growth is hindered by the lack of a skilled workforce capable of performing complex diagnostic tests. This labor shortage can be addressed through collaborations between academia, industry, and governments to train and educate the next generation of animal biotechnology professionals. Companies seeking to capitalize on market opportunities and navigate challenges effectively should focus on building a strong workforce, investing in research and development, and collaborating with industry partners to stay ahead of the competition. By doing so, they will be well-positioned to meet the growing demand for animal health solutions and contribute to the overall growth of the market.

What will be the Size of the Animal Biotechnology Market during the forecast period?

Request Free SampleThe market encompasses a range of applications, including genetic engineering for enhancing animal productivity, reproductive technologies, and the development of animal-based goods and derived products. This sector is driven by the growing demand for animal health solutions, as well as the potential for animal biotechnology in cancer treatment and pharmaceutical development. Public health systems and the animal feed sector also benefit from biotech solutions, such as disease resistance, therapeutic proteins, and diagnostic tests. Molecular biology plays a crucial role in advancing animal health through the identification and prevention of zoonotic diseases and the development of vaccines and drug treatments. Additionally, animal welfare and health management are key areas of focus, with biotech products and cloning techniques contributing to preventative care and protein synthesis. Overall, the market is experiencing significant growth, with ongoing research and innovation in areas such as disease treatment, vaccine development, and animal agriculture efficiency.

How is this Animal Biotechnology Industry segmented?

The animal biotechnology industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments. ProductDrugsVaccinesDiagnostic testsOthersAnimal TypeLivestock/productionCompanionTechnologyCRISPR-Cas9Gene transferGenome editingRNA interferenceNanotechnologyProduct TypeCloning servicesEmbryo biotechnologyGene editingIn vitro fertilization (IVF)Marker assisted selection (MAS)GeographyNorth AmericaUSCanadaEuropeFranceGermanyUKAsiaRest of World (ROW)

By Product Insights

The drugs segment is estimated to witness significant growth during the forecast period.Animal biotechnology encompasses various applications, including genetic composition, genetic engineering, reproductive technologies, animal health, animal-based goods, and animal-derived products. Genetic modification through techniques like electroporation method and random genomic integration is used to create genetically engineered animals with better nutritional profiles, disease resistance, and improved immunological responses. In vitro fertilization and genomic analytic tools are employed in clinical settings for genetic resources and diagnostics tests. Animal agriculture efficiency is enhanced through selective breeding and molecular biology, leading to improvements in cattle health, disease resistance, and the production of animal protein. Animal feed sector relies on feed additives and diagnostics tests for disease prevention and monitoring. Veterinary laboratories and point-of-care testing facilitate quick and accurate diagnosis of animal diseases, such as zoonotic diseases like foot and mouth disease (FMD), salmonella, swine fever, avian influenza, and bovine respiratory disease (BRD). Genetically modified organisms, including genetically altered transgenic animals, are used for cancer treatment, public health systems, and drug development. The use of these technologies in animal health and agriculture is crucial for maintaining animal welfare and ensuring food security.

Get a glance at the market report of share of various segments Request Free Sample

The Drugs seg

The global animal biotechnology market was estimated at 27 billion U.S. dollars in 2023. Of that, North America owned the largest share, with around 35 percent, followed by Asia-Pacific, with around 29 percent.

The Global Animal Biotechnology Market size was valued at USD 24.20 billion in 2023 and is projected to reach USD 44.81 billion by 2032, exhibiting a CAGR of 9.2 % during the forecasts period.The Global Animal Biotechnology Market deals with the application of technologies of biotechnology to improve the health, breeding and production of animals and livestock. This market comprises fields like genetic engineering, molecular diagnostics as well as vaccines including productivity enhancement and resistance to diseases, and health of animals. Some of uses are in production of genetically modified organisms (GMOs) for high growth, disease resistance and better nutritional value. Factors that will drive the market include: there is a growing demand for animal protein; there is growing awareness towards health of animals; there is innovation in the fields of genomics and proteomics. Furthermore, the conscious change towards better means of farming and practice of veterinary medicine is expected to sustain the market in the future.

The size and share of the market is categorized based on Application (Preventive Care For Animals, Development Of Animal Pharmaceuticals, Food Safety And Drug Development) and Product (Diagnostic Tests, Drugs, ReporductiveGenetic Produtcs, Vaccines) and geographical regions (North America, Europe, Asia-Pacific, South America, and Middle-East and Africa).

The global animal biotechnology market valued at USD 15.84 billion in 2023 is projected to grow at a CAGR of 10.56% by 2033. The increasing demand for animal products and the rising prevalence of animal diseases are driving the growth of the market. Additionally, the advent of advanced technologies such as CRISPR-Cas9 and gene transfer is further propelling the market's expansion. Key market trends include the growing adoption of precision livestock farming techniques, increasing investment in animal health research and development, and rising awareness of the ethical concerns associated with animal biotechnology. The market is expected to witness significant growth in emerging economies, particularly in Asia-Pacific and Latin America, where the demand for animal products is rapidly expanding. Key players in the market include Illumina, NEOGEN Corporation, QIAGEN, PerkinElmer, and Pacific Biosciences of California, among others. The global animal biotechnology market size was valued at USD 14.2 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 11.4% from 2023 to 2030. The market is driven by factors such as the rising demand for animal-derived products, the increasing use of biotechnology in animal breeding and healthcare, and the growing awareness of animal welfare. Key drivers for this market are: 1 Gene editing for disease resistance 2 Enhanced nutrition and feed efficiency 3 Precision breeding for desirable traits 4 Diagnostics and personalized treatments 5 Animal welfare and sustainable practices . Potential restraints include: Rising demand for animal protein Technological advancements in genetic engineering Increasing prevalence of animal diseases Growing awareness of animal welfare Expansion of the pet industry .

The global animal biotechnology market, valued at $22.84 billion in 2025, is projected to experience steady growth, driven by several key factors. Increasing demand for animal-derived products, coupled with rising concerns regarding animal health and welfare, are fueling the adoption of advanced biotechnological solutions across various animal sectors. This includes the development of novel vaccines and diagnostics to combat prevalent diseases, enhance productivity, and improve animal welfare. The rising prevalence of zoonotic diseases, highlighting the interconnectedness of animal and human health, further underscores the importance of proactive animal health management, boosting market growth. Technological advancements in genomics, proteomics, and other "omics" technologies are enabling the development of more precise and effective diagnostic tools and therapeutics, further propelling market expansion. Growth is particularly noticeable in segments such as diagnostics, driven by the increasing need for rapid and accurate disease detection. The market is characterized by a competitive landscape with numerous multinational corporations and specialized biotechnology companies vying for market share through strategic partnerships, acquisitions, and the development of innovative products. Geographic growth is expected to be diverse. North America and Europe currently hold significant market share, benefiting from robust regulatory frameworks and substantial investments in research and development. However, rapidly developing economies in Asia-Pacific, particularly China and India, present lucrative growth opportunities driven by expanding livestock populations and increasing adoption of modern farming practices. While challenges remain, such as regulatory hurdles and high development costs for novel biotechnological products, the long-term outlook for the animal biotechnology market remains positive, with a projected Compound Annual Growth Rate (CAGR) of 3.01% from 2025 to 2033. This growth will likely be influenced by continued innovation, government support for agricultural biotechnology, and evolving consumer preferences for ethically and sustainably produced animal products.

Global Animal Biotechnology Market has valued at USD 22.70 billion in 2022 and is anticipated to project impressive growth.

Pages	180
Market Size
Forecast Market Size
CAGR
Fastest Growing Segment
Largest Market
Key Players

AI in Biotechnology Market size was valued at USD 3.5 Billion in 2024 and is projected to reach USD 19.46 Billion by 2032, growing at a CAGR of 21% during the forecasted period 2026 to 2032.

The AI in Biotechnology Market is driven by the growing need for accelerated drug discovery, precision medicine, and genomic research. AI-powered algorithms enhance data analysis, optimize clinical trials, and improve target identification, reducing time and costs associated with drug development. The rising adoption of machine learning and deep learning in bioinformatics, protein structure prediction, and personalized treatment planning further boosts market growth. Additionally, increasing investments in AI-driven biotech startups, strategic collaborations between tech and pharmaceutical companies, and advancements in computational biology contribute to the market’s expansion. Regulatory support for AI integration in biotech research and the rising demand for automation in laboratory workflows also fuel the adoption of AI in biotechnology.

The size and share of the market is categorized based on Type (Hardware, Software and Services) and Application (Agriculture Biotechnology, Medical Biotechnology, Animal Biotechnology, Industrial Biotechnology, Others) and geographical regions (North America, Europe, Asia-Pacific, South America, and Middle-East and Africa).

Animal Serum Product Market size was valued at USD 1.58 Billion in 2023 and is projected to reach USD 5.49 Billion by 2031, growing at a CAGR of 15.39% during the forecast period 2024-2031.

Global Animal Serum Product Market

The market drivers for the Animal Serum Product Market can be influenced by various factors. These may include:

Increasing Demand for Biopharmaceuticals: The biopharmaceutical sector is witnessing rapid growth due to the rising prevalence of chronic diseases and the need for innovative therapeutics. As a result, animal serum products are increasingly utilized in cell culture and vaccine development. The surge in research and development activities in the biopharmaceutical space necessitates high-quality animal serum, which serves as a nutrient-rich substrate essential for the growth of live cells. Furthermore, advancements in personalized medicine are pushing the demand for tailored biopharmaceutical products, leading to an augmented need for specialized animal serum formulations. This growth trajectory significantly propels the animal serum product market.
Advancements in Production Technologies: Innovations in serum production technologies, including improved extraction and purification processes, have enhanced the quality and yield of animal serum products. These advancements ensure that the serum produced is free from contaminants and meets stringent regulatory standards, making it more appealing to end-users in research and industrial applications. Enhanced technologies facilitate the production of specialized serums tailored for specific applications, capturing a broader market segment. Moreover, as companies invest in automation and bioprocessing technologies, the production costs are expected to decrease, leading to competitive pricing and increased adoption of animal serum products across various sectors, including pharmaceuticals and diagnostics.
Growing Biotechnology Sector: The biotechnology sector is expanding rapidly, and it heavily relies on animal serum products for various applications, including research, diagnostics, and therapeutics. As genetic engineering, molecular biology, and proteomics advance, the need for high-quality serum preparations in cell culture experiments becomes paramount. The growing number of biotech startups and research institutions worldwide is driving a heightened demand for animal serum, as these entities require reliable and robust serum solutions to conduct experiments and develop novel therapies. This burgeoning biotechnology landscape is a critical driver for the animal serum product market, reflecting the integral role of serum in facilitating biotech innovations.
Rising Animal Health Concerns: The increasing awareness of animal health and welfare is driving the demand for quality animal serum products. Veterinary research, aimed at developing vaccines and treatment protocols for various animal diseases, utilizes serum extensively for experimentation and formulation. Moreover, the livestock sector is under pressure to enhance production efficiency while minimizing disease outbreaks. As a result, there is a growing emphasis on preventative care and disease management, contributing to the consumption of animal serum for vaccine creation and diagnostics. This trend is set to continue, fueled by increasing investments in veterinary research and concerns surrounding zoonotic diseases, establishing a robust demand in the animal serum market.
Regulatory Compliance and Quality Assurance: The animal serum product market is significantly influenced by stringent regulatory standards imposed by authorities such as the FDA and EMA. The emphasis on quality assurance and safety in production processes has resulted in increased demand for certified animal serum products that meet these regulatory requirements. Companies are focusing on compliance with Good Manufacturing Practices (GMP) and other quality standards to ensure that their products are safe for clinical and research applications. This focus on regulatory compliance not only enhances the credibility of animal serum products but also drives demand from end-users who prioritize safety and efficacy, thereby propelling the market forward.
Expansion of Research and Development Activities: Increased investment in research and development by both academic institutions and private companies plays a crucial role in driving the animal serum product market. With a growing emphasis on developing novel therapies and diagnostics, R&D activities are expanding in fields such as immunology, oncology, and infectious diseases. This surge in R&D initiatives necessitates the use of various biological materials, including animal serum, for experimental validation and clinical trials. As research funding escalates and collaborations between academia and industry intensify, the demand for animal serum products is set to rise, marking a significant driver for market growth in the coming years.

Agricultural Biotechnology Market size was valued at USD 51.12 Billion in 2023 and is projected to reach USD 100.32 Billion by 2031, growing at a CAGR of 9.70% from 2024 to 2031.

Agricultural biotechnology is the use of scientific tools and procedures on living organisms used in agriculture. Genetic engineering, molecular markers, and tissue culture are used to improve crops, livestock, and microbes for higher yields, disease resistance, and overall food production efficiency.
Agricultural biotechnology has a wide range of applications that are altering the agricultural industry. Biotechnology enables the creation of genetically modified crops (GMOs) with enhanced characteristics such as pest and disease resistance, higher yields, and greater tolerance to environmental challenges such as drought or salinity. Furthermore, procedures such as tissue culture allow for the large-scale creation of disease-free plantlets, which speeds up propagation and ensures healthy crops.
Biotechnology can be used to develop crops with improved nutritional profiles, such as fruits and vegetables high in vitamins and antioxidants. It also enables the production of crops with longer shelf lives, which reduces food spoilage and waste. These innovations help to provide a more secure and nutritious food supply for a growing global population.
The future of agricultural biotechnology holds promising breakthroughs that could transform food production. Expect to see more accurate gene editing techniques for generating crops that are resistant to pests, diseases, and extreme weather conditions. This could result in higher crop yields and better food security, especially in climate-affected areas.
Furthermore, advancements in nitrogen fixation and vertical farming show promise for more sustainable and resource-efficient agricultural techniques, lowering environmental impact and providing a secure food supply for a growing global population.

Rising Demand for Food Security: As the world’s population rises, providing enough and consistent food supplies becomes an urgent challenge. Agricultural biotechnology provides solutions by increasing agricultural yields, improving disease resistance, and creating more resilient crops that can survive harsher weather conditions.
Focus on Sustainable Agriculture: Traditional farming techniques can have serious environmental consequences. Agricultural biotechnology is paving the door for more sustainable alternatives, such as nitrogen-fixing crops that reduce the need for synthetic fertilizers and vertical farming practices that conserve land and water.
Growing Consumer Interest in Nutrition and Food Quality: Consumers are seeking healthier, more nutritious foods. Agricultural biotechnology can help meet this demand by producing crops with higher nutritional value or longer shelf life, which reduces food waste.
Pest and Disease Control: Crop losses due to pests and diseases are a major threat to global food security. Agricultural biotechnology provides solutions by developing pest-resistant crops and biopesticides, which reduces dependency on toxic chemical pesticides.
Advancements in Gene Editing Technology: CRISPR and other gene editing tools are transforming agricultural biotechnology. These precise tools enable scientists to make specific modifications in crops, resulting in speedier innovation and more sustainable solutions.

The global animal model market is estimated to garner a revenue of around US$ 1,943.3 million in 2024. Animals possess a shorter life cycle, a high genotype resemblance, and are easy to test in laboratories.

Report Attribute	Details
Animal Model Market Revenue (2024)	US$ 1,943.3 million
Market Anticipated Forecast Value (2034)	US$ 3,476.8 million
Market Projected Growth Rate (2024 to 2034)	6%

Global Animal Model Market Analysis During Historical Period from 2019 to 2023 Compared to Forecast Outlook for 2024 to 2034

Historical Market CAGR (2019 to 2023)	6.4%
Forecasted Market CAGR (2024 to 2034)	6%

Country-wise Insights

Regional Market Comparison	CAGR (2024 to 2034)
United States	6.7%
Germany	8.2%
United Kingdom	6.6%
Japan	4.7%
China	6.1%

Category-wise Insights

Attributes	Details
Top Species Type or Segment	Rats
Market Share in 2024	37.3%

Attributes	Details
Top Application Type	Drug Discovery and Development
Market Share in 2024	54.4%

Animal Model Market Report Scope

Attribute	Details
Estimated Market Size (2024)	US$ 1,943.3 million
Projected Market Size (2034)	US$ 3,476.8 million
Anticipated Growth Rate (2024 to 2034)	6%
Forecast Period	2024 to 2034
Historical Data Available for	2019 to 2023
Market Analysis	US$ million or billion for Value and Units for Volume
Key Regions Covered	North America, Latin America, Europe, Middle East & Africa (MEA), East Asia, South Asia and Oceania
Key Countries Covered	United States, Canada, Brazil, Mexico, Germany, Spain, Italy, France, United Kingdom, Russia, China, India, Australia & New Zealand, GCC Countries, and South Africa
Key Segments Covered	By Species Type, By Application, By End User, and By Region
Key Companies Profiled	Charles River Laboratories International, Inc. Horizon Discovery Group plc. The Jackson Laboratory Taconic Biosciences, Inc. Genoway SA Eurofins Scientific SE Crown Bioscience, Inc. Envigo CRS SA Transposagen Biopharmaceuticals, Inc.
Customization & Pricing	Available upon Request

Global Blue Biotechnology market size was valued at $3.07 Billion in 2022 and it is forecasted to reach $5.34 Billion by 2030. Blue Biotechnology Industry's Compound Annual Growth Rate will be 8.24% from 2023 to 2030. Factors Affecting Blue Biotechnology Market Growth

Increasing demand for blue biotechnology products in cosmetic and pharmaceutical industries will boost the market growth

Marine microorganisms are helpful, and the enzymes they create are healthier than those produced by terrestrial microbes due to their unique traits. Numerous cosmetic products, such as moisturizers, vitamin C complexes, anti-aging formulas, and many more, are made with these components. The market for blue biotechnology is being stimulated by the growing use of marine products in the food, cosmetics, and agricultural sectors. Moreover, the global market for blue biotechnology is growing significantly as a result of increased research and development spending caused by the expansion of biotechnology development.

Restraining Factor for Blue Biotechnology Market Growth:

Government regulation and high cost are limiting market expansion

The market growth may be constrained in the projected period by the expensive discovery procedure and the government's rigorous rules. Technical difficulties brought on by the costly discovery process, the limited capacity for organism development in the lab, significant financial difficulties caused by the relatively low profile of blue biotechnology, which results in underfunding as well as legal and regulatory difficulties, particularly with regard to access to marine resources, all these factors hinder the growth of the blue biotechnology market.

Impact of the COVID-19 Pandemic on the Blue Biotechnology Market:

The COVID-19 pandemic had an adverse impact on the blue biotechnology market's growth in 2020, as well as demand and output. A shift in focus toward the increasing need for the development of treatments and vaccines as a result of the high prevalence of COVID-19 in several countries in 2020 has an influence on supply and demand in the blue biotechnology industry. The limitations imposed by various countries had an influence on the production of blue biotechnology products and their supply chain. Many supply chain operations are delayed as a result. Thus, the COVID-19 pandemic negatively impacted the blue biotechnology market. Introduction of Blue Biotechnology

Blue biotechnology is a combination of marine and aquatic animals with technology to provide a new energy source and can be utilized to extract novel active chemicals, create novel pharmaceuticals, or boost the production and safety of seafood. It has the capacity to provide solutions to any issue relating to the need for food, human health, and environmental issues. Through the use of zero-waste recirculation, preventative treatment measures, and modifications in the food supply, blue biotechnology will aid in promoting animal welfare and increasing the sustainability of production. Health care and the biological sciences are two fields where blue biotechnology has many uses. Through the use of microorganism testing, it aids in the detection of illnesses.

The Global Agricultural Biotechnology market is anticipated to cross USD 80 Billion by 2029, increasing from USD 53 Billion in 2023 with 8.14% CAGR by 2024-29.